CCO Treatment Updates

Preventing and Managing Antiretroviral Side Effects

Preventing and Managing Antiretroviral Side Effects

Module 1 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • High Lipids and Heart Disease
  • Screening and Monitoring
  • Diet, Exercise, and Smoking
  • Switching to a Non-PI Regimen or to Atazanavir
  • Statins, Fibrates, and Other Interventions

Insulin Resistance and Diabetes

Module 2 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Screening and Monitoring
  • Diet and Exercise
  • Switching to a Non-PI Regimen
  • Metformin

Fat Atrophy and Accumulation

Module 3 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Evaluation and Monitoring
  • Lipoatrophy: Risk Factors
  • Switching Antiretrovirals for Fat Atrophy
  • Lipoatrophy: Glitazones, Facial Implants, Leptin Replacement

Liver Toxicity

Module 4 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Risk Factors
  • Association With NNRTIs, PIs, and NRTIs
  • Evaluation and Monitoring
  • Preventing and Managing Hepatotoxicity

High Lactates and Lactic Acidosis

Module 5 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Risk Factors
  • Screening and Monitoring
  • Preventing and Managing Lactic Acidosis

Peripheral Neuropathy

Module 6 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Diagnosing Peripheral Neuropathy
  • Stopping or Switching NRTIs
  • Mechanism-Based Agents
  • Symptom-Relief Agents

Osteopenia and Osteonecrosis

Module 7 of 7

Faculty:
Mark Mascolini


Topics covered include:

  • General Overview
  • Risk Factors For Bone Loss
  • Antiretrovirals and Bone Loss in Children
  • Screening For and Diagnosing Bone Loss
  • Preventing Bone Loss
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.